S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,254.11 (+0.58%)
DOW   33,099.55 (+0.29%)
QQQ   358.54 (+1.02%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Forecast, Price & News

$12.50
-0.16 (-1.26%)
(As of 12:06 PM ET)
Compare
Today's Range
$12.34
$12.67
50-Day Range
$12.43
$15.29
52-Week Range
$11.75
$16.52
Volume
23,249 shs
Average Volume
98,655 shs
Market Capitalization
$506.25 million
P/E Ratio
15.43
Dividend Yield
3.84%
Price Target
$18.67

Phibro Animal Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
50.8% Upside
$18.67 Price Target
Short Interest
Bearish
2.10% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-3.93
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
9.24%
From $1.19 to $1.30 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.75 out of 5 stars

Medical Sector

85th out of 965 stocks

Pharmaceutical Preparations Industry

20th out of 449 stocks


PAHC stock logo

About Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

PAHC Price History

PAHC Stock News Headlines

Why Is Phibro (PAHC) Down 10.9% Since Last Earnings Report?
Warren Buffett: Stark Warning On Inflation
According to a recent letter to Berkshire Hathaway shareholders, “Billionaire Investment Guru Warren Buffett issues stark inflation warning”. The new numbers have shown a comeback for inflation, surging to its highest levels in six months, and it’s now looking like there’s little chance our policy makers can put this cat back in the bag. That’s why it’s critical you heed Warren’s Buffett’s advice and “brace yourself”, before it’s too late. Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!
Why Shares of Phibro Animal Health Are Dropping This Week
Where Phibro Animal Health Stands With Analysts
Warren Buffett: Stark Warning On Inflation
According to a recent letter to Berkshire Hathaway shareholders, “Billionaire Investment Guru Warren Buffett issues stark inflation warning”. The new numbers have shown a comeback for inflation, surging to its highest levels in six months, and it’s now looking like there’s little chance our policy makers can put this cat back in the bag. That’s why it’s critical you heed Warren’s Buffett’s advice and “brace yourself”, before it’s too late. Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!
Q4 2023 Phibro Animal Health Corp Earnings Call
Earnings Outlook For Phibro Animal Health
What Wall Street expects from Phibro Animal Health A's earnings
Phibro's (PAHC) Sales Hurt by Rising Costs, FX Headwind
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Company Calendar

Last Earnings
8/31/2023
Ex-Dividend for 9/27 Dividend
9/05/2023
Dividend Payable
9/27/2023
Today
10/04/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PAHC
Employees
1,920
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.67
High Stock Price Forecast
$21.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+47.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$32.61 million
Pretax Margin
5.53%

Debt

Sales & Book Value

Annual Sales
$977.90 million
Cash Flow
$2.06 per share
Book Value
$6.97 per share

Miscellaneous

Free Float
20,227,000
Market Cap
$512.73 million
Optionable
Optionable
Beta
0.63
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Jack Clifford BendheimMr. Jack Clifford Bendheim (Age 76)
    Chairman, Pres & CEO
    Comp: $2.9M
  • Mr. Damian Finio (Age 53)
    Chief Financial Officer
    Comp: $567.46k
  • Mr. Larry L. Miller (Age 59)
    Chief Operating Officer
    Comp: $774.91k
  • Mr. Daniel M. Bendheim (Age 51)
    Exec. VP of Corp. Strategy & Director
    Comp: $548.18k
  • Mr. Rob Aukerman (Age 65)
    Pres of North America Region
    Comp: $619.27k
  • Ms. Judith A. Weinstein (Age 54)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Ms. Lisa A. Escudero (Age 61)
    Sr. VP of HR
  • Mr. Jonathan Bendheim (Age 47)
    Pres of MACIE Region, GM of Israel Operations & Director
  • Mr. Ramon Fuenmayor
    Pres South America Region
  • Mr. Samson Li (Age 51)
    Pres of Asia Pacific Region













PAHC Stock - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PAHC shares.
View PAHC analyst ratings
or view top-rated stocks.

What is Phibro Animal Health's stock price forecast for 2023?

3 Wall Street analysts have issued 12 month price targets for Phibro Animal Health's shares. Their PAHC share price forecasts range from $17.00 to $21.00. On average, they predict the company's stock price to reach $18.67 in the next twelve months. This suggests a possible upside of 47.4% from the stock's current price.
View analysts price targets for PAHC
or view top-rated stocks among Wall Street analysts.

How have PAHC shares performed in 2023?

Phibro Animal Health's stock was trading at $13.41 at the start of the year. Since then, PAHC stock has decreased by 5.6% and is now trading at $12.66.
View the best growth stocks for 2023 here
.

When is Phibro Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our PAHC earnings forecast
.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) released its quarterly earnings results on Thursday, August, 31st. The company reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by $0.02. The firm earned $255 million during the quarter, compared to analysts' expectations of $256.68 million. Phibro Animal Health had a net margin of 3.33% and a trailing twelve-month return on equity of 18.05%. During the same quarter in the previous year, the business posted $0.36 EPS.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Tuesday, July 25th. Investors of record on Wednesday, September 6th will be given a dividend of $0.12 per share on Wednesday, September 27th. This represents a $0.48 dividend on an annualized basis and a yield of 3.79%. The ex-dividend date is Tuesday, September 5th.
Read our dividend analysis for PAHC
.

What ETFs hold Phibro Animal Health's stock?

ETFs with the largest weight of Phibro Animal Health (NASDAQ:PAHC) stock in their portfolio include Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD).iShares U.S. Pharmaceuticals ETF (IHE).

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.77%. The dividend payout ratio is 59.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 36.92% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health updated its FY24 earnings guidance on Wednesday, August, 30th. The company provided earnings per share guidance of $1.12-1.27 for the period, compared to the consensus EPS estimate of $1.29. The company issued revenue guidance of $1.00-1.05 billion, compared to the consensus revenue estimate of $1.01 billion.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $12.66.

How much money does Phibro Animal Health make?

Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $512.73 million and generates $977.90 million in revenue each year. The company earns $32.61 million in net income (profit) each year or $0.81 on an earnings per share basis.

How many employees does Phibro Animal Health have?

The company employs 1,920 workers across the globe.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399.

This page (NASDAQ:PAHC) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -